Molecular Basis for Proline- and Arginine-Rich Peptide Inhibition of Proteasome
- 1 December 2008
- journal article
- research article
- Published by Elsevier in Journal of Molecular Biology
- Vol. 384 (1) , 219-227
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Myocardial hypertrophy in the absence of external stimuli is induced by angiogenesis in miceJournal of Clinical Investigation, 2007
- Docking of the Proteasomal ATPases' Carboxyl Termini in the 20S Proteasome's α Ring Opens the Gate for Substrate EntryMolecular Cell, 2007
- Proline- and Arginine-Rich Peptides Constitute a Novel Class of Allosteric Inhibitors of Proteasome ActivityBiochemistry, 2003
- Inhibition of ubiquitin-proteasome pathway–mediated IκBα degradation by a naturally occurring antibacterial peptideJournal of Clinical Investigation, 2000
- Signal-dependent and -independent Degradation of Free and NF-κB-bound IκBαJournal of Biological Chemistry, 2000
- PR-39, a Syndecan-inducing Antimicrobial Peptide, Binds and Affects p130CasJournal of Biological Chemistry, 1998
- Structure of 20S proteasome from yeast at 2.4Å resolutionNature, 1997
- PR-39, a proline-rich peptide antibiotic from pig, and FALL-39, a tentative human counterpartVeterinary Immunology and Immunopathology, 1996
- Influence of proline residues on protein conformationJournal of Molecular Biology, 1991
- Application of phase sensitive two-dimensional correlated spectroscopy (COSY) for measurements of 1H-1H spin-spin coupling constants in proteinsBiochemical and Biophysical Research Communications, 1983